INS and Hypoglycemia: The Diabetes Control and Complications Trial (DCCT) [59] demonstrated the long-term benefits of intensive insulin treatment; however, the increased risk of hypoglycaemia and increased staff resources used in the DCCT have perhaps limited the adoption of this approach even more widely.